Laura V Bownes1, Raoud Marayati1, Colin H Quinn1, Sara C Hutchins1, Jerry E Stewart1, Joshua C Anderson2, Christopher D Willey2, Pran K Datta3, Elizabeth A Beierle4. 1. Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, United States of America. 2. Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, United States of America. 3. Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, United States of America. 4. Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, United States of America. Electronic address: elizabeth.beierle@childrensal.org.
Abstract
BACKGROUND: Serine-threonine kinase receptor associated protein (STRAP), a scaffolding protein, is upregulated in many solid tumors. As such, we hypothesized that STRAP may be overexpressed in neuroblastoma tumors and may play a role in neuroblastoma tumor progression. METHODS: We examined two publicly available neuroblastoma patient databases, GSE49710 (n = 498) and GSE49711 (n = 498), to investigate STRAP expression in human specimens. SK-N-AS and SK-N-BE(2) human neuroblastoma cell lines were stably transfected with STRAP overexpression (OE) plasmid, and their resulting phenotype studied. PamChip® kinomic peptide microarray evaluated the effects of STRAP overexpression on kinase activation. RESULTS: In human specimens, higher STRAP expression correlated with high-risk disease, unfavorable histology, and decreased overall neuroblastoma patient survival. STRAP OE in neuroblastoma cell lines led to increased proliferation, growth, supported a stem-like phenotype and activated downstream FAK targets. When FAK was targeted with the small molecule FAK inhibitor, PF-573,228, STRAP OE neuroblastoma cells had significantly decreased growth compared to control empty vector cells. CONCLUSION: Increased STRAP expression in neuroblastoma was associated with unfavorable tumor characteristics. STRAP OE resulted in increased kinomic activity of FAK. These findings suggest that the poorer outcomes in neuroblastoma tumors associated with STRAP overexpression may be secondary to FAK activation.
BACKGROUND: Serine-threonine kinase receptor associated protein (STRAP), a scaffolding protein, is upregulated in many solid tumors. As such, we hypothesized that STRAP may be overexpressed in neuroblastoma tumors and may play a role in neuroblastoma tumor progression. METHODS: We examined two publicly available neuroblastoma patient databases, GSE49710 (n = 498) and GSE49711 (n = 498), to investigate STRAP expression in human specimens. SK-N-AS and SK-N-BE(2) human neuroblastoma cell lines were stably transfected with STRAP overexpression (OE) plasmid, and their resulting phenotype studied. PamChip® kinomic peptide microarray evaluated the effects of STRAP overexpression on kinase activation. RESULTS: In human specimens, higher STRAP expression correlated with high-risk disease, unfavorable histology, and decreased overall neuroblastoma patient survival. STRAP OE in neuroblastoma cell lines led to increased proliferation, growth, supported a stem-like phenotype and activated downstream FAK targets. When FAK was targeted with the small molecule FAK inhibitor, PF-573,228, STRAP OE neuroblastoma cells had significantly decreased growth compared to control empty vector cells. CONCLUSION: Increased STRAP expression in neuroblastoma was associated with unfavorable tumor characteristics. STRAP OE resulted in increased kinomic activity of FAK. These findings suggest that the poorer outcomes in neuroblastoma tumors associated with STRAP overexpression may be secondary to FAK activation.
Authors: S Matsuda; R Katsumata; T Okuda; T Yamamoto; K Miyazaki; T Senga; K Machida; A A Thant; S Nakatsugawa; M Hamaguchi Journal: Cancer Res Date: 2000-01-01 Impact factor: 12.701
Authors: Elizabeth A Beierle; Nicole A Massoll; Joseph Hartwich; Elena V Kurenova; Vita M Golubovskaya; William G Cance; Patrick McGrady; Wendy B London Journal: Clin Cancer Res Date: 2008-06-01 Impact factor: 12.531
Authors: Shan Li; Pengyu Liu; Wenhui Wang; Kostandinos Sideras; Harmen J G van de Werken; Marieke van der Heide; Wanlu Cao; Marla Lavrijsen; Maikel P Peppelenbosch; Marco Bruno; Qiuwei Pan; Ron Smits Journal: Mol Cancer Res Date: 2018-09-26 Impact factor: 5.852
Authors: Manuel Hidalgo; Frederic Amant; Andrew V Biankin; Eva Budinská; Annette T Byrne; Carlos Caldas; Robert B Clarke; Steven de Jong; Jos Jonkers; Gunhild Mari Mælandsmo; Sergio Roman-Roman; Joan Seoane; Livio Trusolino; Alberto Villanueva Journal: Cancer Discov Date: 2014-07-15 Impact factor: 39.397
Authors: Claudia Blattmann; Markus Thiemann; Albrecht Stenzinger; Eva K Roth; Anne Dittmar; Hendrik Witt; Burkhard Lehner; Eva Renker; Manfred Jugold; Viktoria Eichwald; Wilko Weichert; Peter E Huber; Andreas E Kulozik Journal: J Transl Med Date: 2015-04-30 Impact factor: 5.531